Glycorex Transplantation
1.635
SEK
+0.93 %
GTAB B
NGM Main Regulated
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
+0.93%
-18.05%
-2.97%
+57.97%
+23.4%
+3.48%
-82.49%
-84.93%
-83.9%
Glycorex Transplantation is a biotechnology company. The company conducts research, development, and marketing within the field of organ transplantation. The main product of the company, Glycosorb-ABO, enables transplants irrespective of the blood type of the donors and the recipients. Transplants with the help of the company's product have been carried out worldwide. Glycorex Transplantation was founded in 1996 and is based in Lund.
Read moreMarket cap
120.75M SEK
Turnover
20.56K SEK
Revenue
29.96M
EBIT %
-101.07 %
P/E
-
Dividend yield-%
-
Financial calendar
27/2
2025
Annual report '24
ShowingAll content types
Glycorex Transplantation AB (GTAB B): Leverans av produkter för utvärdering i USA
Glycorex Transplantation AB (GTAB B): In vitro-tester i USA
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools